Chiusura precedente | 3,8200 |
Aperto | 3,8900 |
Denaro | 3,8000 x 100 |
Lettera | 3,9600 x 100 |
Min-Max giorno | 3,7802 - 3,9500 |
Intervallo di 52 settimane | 3,4400 - 6,2100 |
Volume | |
Media Volume | 93.391 |
Capitalizzazione | 167,172M |
Beta (5 anni mensile) | 1,45 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -0,0800 |
Prossima data utili | 07 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 6,88 |
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated
Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2023. Jim Green, Chairman and CEO said, “We are encouraged by the continuation of a strong start to the fiscal year, with growth from new produc
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The presentation will begin at 11:30 a.m. ET on Wednesday, August 16th and can be accessed live here. The presentation will also be archived on the Investor